Tempus expands multi-year collaboration with Gilead for oncology research
Go back to Tempus expands multi-year collaboration with Gilead for oncology research| Gilead Sciences (NASDAQ: GILD) | Delayed: 125.73 +0.86 (0.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $124.87 | 52 Week High | $108.63 | |||
| Open | $126.63 | 52 Week Low | $71.39 | |||
| Day High | $126.63 | P/E | 69.46 | |||
| Day Low | $124.44 | EPS | $1.81 | |||
| Volume | 1,589,989 | |||||
| StemCells, Inc. (NASDAQ: TEM) | Delayed: 48.73 +0.88 (1.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $47.85 | 52 Week High | $0.45 | |||
| Open | $47.00 | 52 Week Low | $0.37 | |||
| Day High | $49.09 | P/E | N/A | |||
| Day Low | $46.68 | EPS | $-0.31 | |||
| Volume | 1,609,805 | |||||
